David L. Fitzgerald

Array ( [id] => 3762912 [patent_doc_number] => 05772992 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors' [patent_app_type] => 1 [patent_app_number] => 8/191973 [patent_app_country] => US [patent_app_date] => 1994-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 39173 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/772/05772992.pdf [firstpage_image] =>[orig_patent_app_number] => 191973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4183748 [patent_doc_number] => 06153183 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Co-administration of interleukin-3 mutant polypeptides with CSF\'s or cytokines for multi-lineage hematopoietic cell production' [patent_app_type] => 1 [patent_app_number] => 8/193373 [patent_app_country] => US [patent_app_date] => 1994-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 51809 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153183.pdf [firstpage_image] =>[orig_patent_app_number] => 193373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4106395 [patent_doc_number] => 06057133 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Multivariant human IL-3 fusion proteins and their recombinant production' [patent_app_type] => 1 [patent_app_number] => 8/192325 [patent_app_country] => US [patent_app_date] => 1994-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 55848 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 452 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057133.pdf [firstpage_image] =>[orig_patent_app_number] => 192325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3552279 [patent_doc_number] => 05548063 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-20 [patent_title] => 'Retinoic acid receptor alpha proteins' [patent_app_type] => 1 [patent_app_number] => 8/179912 [patent_app_country] => US [patent_app_date] => 1994-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 13733 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/548/05548063.pdf [firstpage_image] =>[orig_patent_app_number] => 179912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3495535 [patent_doc_number] => 05532157 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-02 [patent_title] => 'Host cell line LVIP2.0Zc, useful in assays to identify ligands and ant agonists of G protein-coupled receptors' [patent_app_type] => 1 [patent_app_number] => 8/176310 [patent_app_country] => US [patent_app_date] => 1994-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 4957 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/532/05532157.pdf [firstpage_image] =>[orig_patent_app_number] => 176310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3548818 [patent_doc_number] => 05571692 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-05 [patent_title] => 'Retinoic acid receptor .alpha., vectors and cells comprising the same DNA encoding' [patent_app_type] => 1 [patent_app_number] => 8/168686 [patent_app_country] => US [patent_app_date] => 1993-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 13715 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/571/05571692.pdf [firstpage_image] =>[orig_patent_app_number] => 168686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726241 [patent_doc_number] => 05670360 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Mammalian receptors for glucagon-like-peptide-1 (GLP-1), corresponding DNA and recombinant expression systems, and screening assays for GLP-1 agonists and enhancers' [patent_app_type] => 1 [patent_app_number] => 8/142439 [patent_app_country] => US [patent_app_date] => 1993-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7516 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670360.pdf [firstpage_image] =>[orig_patent_app_number] => 142439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685425 [patent_doc_number] => 05663070 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM' [patent_app_type] => 1 [patent_app_number] => 8/152443 [patent_app_country] => US [patent_app_date] => 1993-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 6876 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663070.pdf [firstpage_image] =>[orig_patent_app_number] => 152443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3525916 [patent_doc_number] => 05582824 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Recombinant DES-CYS-TYR-CYS human immune interferon' [patent_app_type] => 1 [patent_app_number] => 8/150772 [patent_app_country] => US [patent_app_date] => 1993-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 12839 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/582/05582824.pdf [firstpage_image] =>[orig_patent_app_number] => 150772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4040730 [patent_doc_number] => 05874236 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'DNA encoding human calcium channel .alpha.-.sub.1A, .beta..sub.1, .beta.-.sub.2, and .beta.-.sub.4 subunits, and assays using cells that express the subunits' [patent_app_type] => 1 [patent_app_number] => 8/149097 [patent_app_country] => US [patent_app_date] => 1993-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44804 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874236.pdf [firstpage_image] =>[orig_patent_app_number] => 149097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3532516 [patent_doc_number] => 05556780 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-17 [patent_title] => 'CDNAS encoding mouse and rat type-2 angiotensin II receptors and their expression in host cells' [patent_app_type] => 1 [patent_app_number] => 8/148209 [patent_app_country] => US [patent_app_date] => 1993-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 10750 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/556/05556780.pdf [firstpage_image] =>[orig_patent_app_number] => 148209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3570436 [patent_doc_number] => 05538892 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-23 [patent_title] => 'Nucleic acids encoding a TGF-.beta. type 1 receptor' [patent_app_type] => 1 [patent_app_number] => 8/149105 [patent_app_country] => US [patent_app_date] => 1993-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 29 [patent_no_of_words] => 14320 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/538/05538892.pdf [firstpage_image] =>[orig_patent_app_number] => 149105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3101574 [patent_doc_number] => 05447852 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-05 [patent_title] => 'DNA encoding cyclophilin C, and recombinant methods employing it' [patent_app_type] => 1 [patent_app_number] => 8/142897 [patent_app_country] => US [patent_app_date] => 1993-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13412 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/447/05447852.pdf [firstpage_image] =>[orig_patent_app_number] => 142897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3881580 [patent_doc_number] => 05723117 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Use of interleukin-1 (IL-1) to inhibit development of hepatitis' [patent_app_type] => 1 [patent_app_number] => 8/139862 [patent_app_country] => US [patent_app_date] => 1993-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 12531 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723117.pdf [firstpage_image] =>[orig_patent_app_number] => 139862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619858 [patent_doc_number] => 05641656 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them' [patent_app_type] => 1 [patent_app_number] => 8/139909 [patent_app_country] => US [patent_app_date] => 1993-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4956 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641656.pdf [firstpage_image] =>[orig_patent_app_number] => 139909 [rel_patent_id] =>[rel_patent_doc_number] =>)